114450 — Green LifeScience Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Green LifeScience Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	1,196	-1,059	-3,136	-3,526	-16,358
Depreciation
Amortisation
Non-Cash Items	-695	39.9	-1,428	247	12,157
Unusual Items
Other Non-Cash Items
Changes in Working Capital	360	254	2,611	-4,042	2,095
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	4,242	1,902	611	-4,552	370
Capital Expenditures	-3,600	-2,667	-3,444	-1,478	-475
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	6,518	-5,223	2,842	6,535	7,991
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	2,918	-7,890	-602	5,057	7,516
Financing Cash Flow Items	—	—	—	—	-2,031
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-182	900	961	-1,071	-4,307
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	6,990	-5,112	986	-574	3,533